Sundar PichaiSundar Pichai earned $164M in 2023

Michael C. Greiner is the Chief Financial Officer and Chief Transformation Officer at Avanos Medical, Inc., where he plays a key role in guiding the company's financial strategies and growth. Since joining Avanos in 2020, he has been instrumental in...

Quick Links
A

Michael C. Greiner

CEO of Avanos Medical

Education

Not specified

Field of Expertise

Finance & Banking - Finance

Sector of Economy

Healthcare

Born

January 1, 1972 - 53 years ago

CEO of Avanos Medical for

0 years 5 months (Oct 2024 - Present)

Previous Experience

CFO at AngioDynamics, Inc.

Rivals

Competitors/colleagues of Michael C. Greiner

Holdings

See how much did Michael C. Greiner make over time.

Michael C. Greiner’s stock holdings have been interesting to follow. While he focuses on performance-based pay and did not vest any stock in 2023, he has been a significant player in the stock's trajectory since he joined Avanos. As of...

Total Stock Sold

$193.94K

ANGO

$42.10K

1,939 ANGO shares

AVNS

$151.84K

8,000 AVNS shares

What if they kept their stock?

If Michael C. Greiner didn't sell their stock, today they would have:
Extra ANGO1,939 shares worth $19.29K and AVNS8,000 shares worth $211.20K.
This is 18.85% and $36.56K more than what they got when they sold the stock.

Insider Trading

See recent insider trades of Michael C. Greiner.

AVNS

34,316 shares

AVNS

Mar 7, 2025

Received

AVNS

10,000 shares

AVNS

Dec 3, 2024

Received

AVNS

44,189 shares

AVNS

Oct 29, 2024

Received

AVNS

$153.08K

AVNS at $19.14/share

Mar 14, 2024

Sale

AVNS

$1.10M

AVNS at $19.14/share

Mar 6, 2024

Received

AVNS

36,350 shares

AVNS

Mar 6, 2023

Received

AVNS

34,619 shares

AVNS

Mar 6, 2023

Received

AVNS

30,575 shares

AVNS

Mar 4, 2022

Received

AVNS

$750.07K

AVNS at $47.29/share

Mar 17, 2021

Received

AVNS

$1.13M

AVNS at $30.67/share

May 7, 2020

Received

Compensation History

See how much did Michael C. Greiner make over time.

In 2023, Michael C. Greiner earned a total compensation of about $723,262, comprising a salary of $390,250 and a bonus of $333,012. The bonus was based on achieving specific performance targets, pointing to his focus on driving results. His compensation reflects a pay-for-performance structure, aligning his financial interests with the company's objectives. While no stock options or grants vested in 2023, Greiner's past compensation from previous years demonstrates a substantial and consistent growth in line with the company’s strategic goals. This structure encourages him to pursue key performance metrics, contributing positively to Avanos's growth.

Year

2023

Total Compensation

$723.26K

Salary

$390.25K

Board Justification

The compensation program is designed to align executive pay with performance metrics that drive company success, ensuring that compensation reflects both individual and company performance.

Bonus

$333.01K

Board Justification

Annual cash incentive payout based on performance metrics achieved in 2023, resulting in an 84.7% payout percentage.

Other

$0.00

Board Justification

No additional compensation reported outside of salary, bonus, and stock awards.

Restricted Stock

$0.00(0 RSU)

Board Justification

No stock was vested in 2023 as the focus was on performance-based awards that will vest in future years.

Performance Metrics

Performance metrics for 2023 included adjusted net sales, adjusted EBITDA, and strategic initiatives.

Other Avanos Medical CEOs

Here are other CEOs of Avanos Medical